Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Grail Launches Galleri Multi-Cancer Test In US; Future Of Merger With Illumina Is Still Uncertain

Jun 07 2021

• By Reed Miller

Artwork of cancer cells dividing. - Image ID: E1KHA2 — • Source: Alamy

Related Content

US Government Opposes Proposed Illumina/Grail Merger

Mar 31 2021

Illumina Will Pay $8Bn To Buy Back Cancer Screening Start-Up Grail

Sep 21 2020

Grail Files For $100M IPO, Plans To Launch Multi-Cancer Early Detection Test In 2021

Sep 09 2020

Early Cancer Detection: Will New Screening Technology Disrupt Cancer Care?

Dec 09 2020

Grail’s Liquid Biopsy Can Detect Numerous Deadly Cancer Types Early

Apr 01 2020

Related Companies

GRAIL Inc.

Additional Topics

Launches M & A Clinical Trials Approvals Commercial Companies Cancer In Vitro Diagnostics Diagnostics Medical Device

More from Oncology

More from Device Area

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window